High-Tech Gründerfonds et al. invest €400,000 in Chromotek

The investment will fund research and development work, aimed at ensuring successful market entry for Chromotek's technology.

The company, founded in 2008, develops inovative reagents for biomedical research. These are used for biomedical screening processes involved in the R&D for pharmaceutical active ingredients. Chromotek aims at commercialising its first products in 2011.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Benelux
• France
• UK / Ireland
• Nordics
• Southern Europe
• CEE
• Early-stage
• Healthcare
• Germany